InvestorsHub Logo
Followers 7
Posts 660
Boards Moderated 0
Alias Born 05/30/2005

Re: None

Friday, 08/21/2015 9:38:57 AM

Friday, August 21, 2015 9:38:57 AM

Post# of 3108
Just a quick note to point out that the fundamental difference between the Celldex and Northwest Bio studies and the CLBS P-III study is that Caladrius has an SPA with the FDA, something that neither Celldex nor NWBO have. It's important, as it guarantees the right to request BLA if they hit the OS marks needed. Both CLDX and NWBO are shooting at less distinct targets with no guarantees of acceptance by the FDA at the end.
GLTA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LSTA News